CASP3 and Miyoshi myopathy: A pan-caspase inhibitor (Z-VAD-FMK) prevented HVJ-E-mediated activation of caspase-3 (Figure 1D) and cell death (Figure 1E), indicating that HVJ-E induced caspase-dependent apoptosis in MM.